Trials / Recruiting
RecruitingNCT06801795
Aviclear for Hidradenitis Suppurativa (HS)
Evaluation of a 1726nm Laser for the Treatment of Hidradenitis Suppurativa (HS)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AviClear | Participants will receive as many as 4 treatments, each treatment lasts approximately 10 minutes, with intervals of up to 5 weeks apart. The treatments will be conducted in person. Participants will be followed at approximately week 5 post-treatment completion (via phone) at 12 weeks and 24 weeks post treatment completion onsite. This is a 1726 nanometer laser treatment |
Timeline
- Start date
- 2025-02-12
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-01-30
- Last updated
- 2026-04-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06801795. Inclusion in this directory is not an endorsement.